Literature DB >> 11341853

The effect of tobacco smoking on subjective symptoms of inadequacy ("not holding") of methadone dose among opiate addicts in methadone maintenance treatment.

Ulrich Tacke1, Kim Wolff, Emily Finch, John Strang.   

Abstract

The objective of this study was to examine the relationship between subjective symptoms of inadequacy of methadone dose (not feeling "held") and tobacco smoking in patients in methadone maintenance treatment (MMT). This was a cross-sectional study of smoking behaviour, investigating subjective, physiological and psychological symptoms. The study took place in a community-based methadone maintenance clinic of a psychiatric teaching hospital in South London. Fifty adult opiate addicts (37 males and 13 females) were on a stable daily methadone dose; the number of cigarettes smoked during the day and previous day of investigation, salivary cotinine measurements and carbon monoxide (CO) from expired air were measured. The Methadone Symptom Checklist (MSC) was used to score withdrawal symptoms encountered in patients not feeling "held" during MMT The Hamilton Anxiety Score was also used. The prevalence of tobacco-smoking was high (98%), with two-thirds (68%) smoking self-fabricated cigarettes ("roll-ups"). Scores from rating scales measuring symptoms of not being "held" correlated with number of cigarettes smoked the previous day (p < 0.05). A similar correlation was found with the Hamilton Anxiety Score. However, there was no correlation between rating scale scores and either salivary cotinine concentration or CO from expired air. Methadone patients who smoke more are significantly more likely to report problems of not feeling "held" by their methadone dose and they also show a higher level of anxiety. However, this increased cigarette consumption is not reflected in increased salivary continine levels or levels of CO in expired air, and it may be that the raised level of anxiety leads to a smoking-pattern consisting of frequent lighting-up of cigarettes or "roll-ups" which are consumed incompletely and/or not smoked by inhalation.

Entities:  

Year:  2001        PMID: 11341853     DOI: 10.1080/13556210020040217

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  12 in total

Review 1.  Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence.

Authors:  Chin B Eap; Thierry Buclin; Pierre Baumann
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  An international systematic review of smoking prevalence in addiction treatment.

Authors:  Joseph Guydish; Emma Passalacqua; Anna Pagano; Cristina Martínez; Thao Le; JongSerl Chun; Barbara Tajima; Lindsay Docto; Daria Garina; Kevin Delucchi
Journal:  Addiction       Date:  2015-09-22       Impact factor: 6.526

3.  Cigarette use is increasing among people with illicit substance use disorders in the United States, 2002-14: emerging disparities in vulnerable populations.

Authors:  Andrea H Weinberger; Misato Gbedemah; Melanie M Wall; Deborah S Hasin; Michael J Zvolensky; Renee D Goodwin
Journal:  Addiction       Date:  2017-12-19       Impact factor: 6.526

4.  Mechanisms and Clinical Features of Co-occurring Opioid and Nicotine Use.

Authors:  Sarah D Lichenstein; Yasmin Zakiniaeiz; Sarah W Yip; Kathleen A Garrison
Journal:  Curr Addict Rep       Date:  2019-04-27

Review 5.  The phenomics and genetics of addictive and affective comorbidity in opioid use disorder.

Authors:  Philip J Freda; Jason H Moore; Henry R Kranzler
Journal:  Drug Alcohol Depend       Date:  2021-02-22       Impact factor: 4.492

6.  The nature of methadone diversion in England: a Merseyside case study.

Authors:  Paul Duffy; Helen Baldwin
Journal:  Harm Reduct J       Date:  2012-01-13

Review 7.  A Systematic Review of Smoking Cessation Interventions for Adults in Substance Abuse Treatment or Recovery.

Authors:  Sarah L Thurgood; Ann McNeill; David Clark-Carter; Leonie S Brose
Journal:  Nicotine Tob Res       Date:  2015-06-11       Impact factor: 4.244

8.  The barriers to smoking cessation in Swiss methadone and buprenorphine-maintained patients.

Authors:  Victoria Wapf; Michael Schaub; Beat Klaeusler; Lukas Boesch; Rudolf Stohler; Dominique Eich
Journal:  Harm Reduct J       Date:  2008-03-18

9.  Psychological Barriers to Tobacco Cessation in Indian Buprenorphine-Naloxone Maintained Patients: A Pilot Study.

Authors:  Piyali Mandal; Raka Jain; Sonali Jhanjee; V Sreenivas
Journal:  Indian J Psychol Med       Date:  2015 Jul-Sep

10.  Smoking and its treatment in addiction services: clients' and staff behaviour and attitudes.

Authors:  Camilla Cookson; John Strang; Elena Ratschen; Gay Sutherland; Emily Finch; Ann McNeill
Journal:  BMC Health Serv Res       Date:  2014-07-14       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.